Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine

Absztrakt
Leírás
Kulcsszavak
Forrás
Journal Of Clinical Oncology. -40 : 8 (2022), p. 855-865. -J. Clin. Oncol. - 0732-183X. - 1527-7755